Literature DB >> 27605371

Impact of practice change in reducing venous thromboembolism in neurocritical overweight patients: 2008-2014.

Sophie Samuel1, Suhas Bajgur2, Jude P Savarraj2, Huimahn A Choi2.   

Abstract

Publications regarding early initiating venous thromboembolism (VTE) prophylaxis have been available since the early 1990s. These recommendations became available in current guidelines on and after 2012. The purpose of this study is to review the practice change in reducing the incidence of VTE in brain injury patients from 2008 to 2014. This was a single-center, retrospective, observational, cohort study. Data was extracted from our data base that included patients over 100 kg from January 2008 to August 2014. Included were all patients admitted with a primary diagnosis of acute brain and spinal injury to neurocritical care unit. Clinical endpoints examined were incidence of bleeding and VTE. A total of 509 patients who met the inclusion criteria were divided into two groups: The previous group (n = 212) included patients from 2008 to 2010, and the recent group (n = 297) included patients from 2011 to 2014. The time for initiating VTE prophylaxis from admission was (median, IQR) 73 h (37-140) vs. 34 h (20-46); p < 0.01. There were no differences in major and minor bleeding complications. Discontinuation of VTE prophylaxis for association with progressive bleeding was not documented in any of the study patients. The incidence of VTE was 10 % (22/212) vs. 5 % (15/297); p = 0.02. In hospital LOS in days was 16 (10-26) vs. 7 (4-15); P < 0.01. In multivariable logistic regression analysis, only the time of the initiation VTE prophylaxis after admission was significantly associated with the occurrence of VTE (median, IQR) 70 h (37-158) vs. 36 h (20-63); OR 1.004, 95 % CI 1.001-1.007; P < 0.01. In this 6-year review of data, early initiation of VTE prophylaxis has decreased the incidence of VTE without clinically documented bleeding complications.

Entities:  

Keywords:  Heparin; Neurosurgery; Risk factors; Venous thromboembolism

Mesh:

Year:  2017        PMID: 27605371     DOI: 10.1007/s11239-016-1422-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  24 in total

1.  Early heparin therapy in patients with spontaneous intracerebral haemorrhage.

Authors:  A Boeer; E Voth; T Henze; H W Prange
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

2.  Prevention of venous thrombosis in patients with acute intracerebral hemorrhage.

Authors:  K Lacut; L Bressollette; G Le Gal; E Etienne; A De Tinteniac; A Renault; F Rouhart; G Besson; J-F Garcia; D Mottier; E Oger
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

3.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association.

Authors:  E Sander Connolly; Alejandro A Rabinstein; J Ricardo Carhuapoma; Colin P Derdeyn; Jacques Dion; Randall T Higashida; Brian L Hoh; Catherine J Kirkness; Andrew M Naidech; Christopher S Ogilvy; Aman B Patel; B Gregory Thompson; Paul Vespa
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

4.  High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients.

Authors:  Sophie Samuel; Emitseilu K Iluonakhamhe; Eileen Adair; Natalie Macdonald; Kiwon Lee; Teresa A Allison; Huimahn A Choi
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

5.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo
Journal:  Stroke       Date:  2015-05-28       Impact factor: 7.914

6.  The incidence of deep vein thrombosis detected by routine surveillance ultrasound in neurosurgery patients receiving dual modality prophylaxis.

Authors:  Patricia C Henwood; Thomas M Kennedy; Lynda Thomson; Taki Galanis; George L Tzanis; Geno J Merli; Walter K Kraft
Journal:  J Thromb Thrombolysis       Date:  2011-08       Impact factor: 2.300

Review 7.  Venous thromboembolism in neurosurgery and neurology patients: a review.

Authors:  M G Hamilton; R D Hull; G F Pineo
Journal:  Neurosurgery       Date:  1994-02       Impact factor: 4.654

8.  Safety and Efficacy of High-Dose Unfractionated Heparin for Prevention of Venous Thromboembolism in Overweight and Obese Patients.

Authors:  Mishna Joy; Eileen Tharp; Heather Hartman; Sara Schepcoff; Jennifer Cortes; Adam Sieg; Mark Mariski; Yeunju Lee; Meghan Murphy; Ghazaleh Ranjbar; Sherouk Sharaf; Gin Yau; Huimahn Alex Choi; Sophie Samuel
Journal:  Pharmacotherapy       Date:  2016-06-29       Impact factor: 4.705

9.  Early administration of low molecular weight heparin after spontaneous intracerebral hemorrhage. A safety analysis.

Authors:  Ines C Kiphuth; Dimitre Staykov; Martin Köhrmann; Tobias Struffert; Gregor Richter; Jurgen Bardutzky; Rainer Kollmar; Mathias Mäurer; Peter D Schellinger; Max-Josef Hilz; Arnd Doerfler; Stefan Schwab; Hagen B Huttner
Journal:  Cerebrovasc Dis       Date:  2008-11-28       Impact factor: 2.762

10.  Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients.

Authors:  Tzu-Fei Wang; Paul E Milligan; Catherine A Wong; Eli N Deal; Mark S Thoelke; Brian F Gage
Journal:  Thromb Haemost       Date:  2013-10-17       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.